The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson FDA UPDATED PEPTIDES APRIL 15, 2026 Most people are already getting this wrong. Today, the FDA updated its 503A compounding categories and removed several peptides from the high risk (Category 2) Order BPC 157 (20mg) Buy Research Peptides Medica Depot The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what